- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06037304
Quality of Life After Shouldice Repair (QoL)
This research project aims to assess the quality of life (QOL) and pain/discomfort experienced by patients who have undergone primary inguinal hernia repair at Shouldice Hospital. Historically, postoperative mortality and symptom improvement have been the main outcomes assessed after hernia surgery, neglecting the patient experience. As QOL gains significance in hernia patient care, this study focuses on evaluating patient QOL before and after surgery, contributing to a better understanding of hernia surgery outcomes.
Study Objectives:
Determine preoperative quality of life. Determine patient-reported quality of life at 1 week after surgery. Determine patient-reported quality of life at 1 month after surgery. Determine patient-reported quality of life at 6 months after surgery. Evaluate changes in quality of life from the preoperative time to 6 months after surgery.
Hypotheses/Research Questions:
Does quality of life change after hernia surgery? What is the quality of life before and after primary unilateral inguinal hernia repair? Does hernia repair improve patient quality of life?
Study Design:
This is a prospective cohort pilot study involving primary unilateral inguinal hernia patients who received Shouldice repair at Shouldice Hospital. It includes chart reviews (medical histories and operative notes) and surveys at preoperative, 1-week, 1-month, and 6-month postoperative time points. Surveys are conducted using the EQ5D3L tool to measure health-related quality of life.
Study Population:
The study population includes male and female patients aged 16-90, of all nationalities and races, capable of English communication, in good general health, who had primary unilateral inguinal hernia repair at Shouldice Hospital. Exclusions encompass patients who had mesh repair, non-inguinal hernias, concurrent hernias, bilateral hernia repair, or emergency surgeries.
Data Collection:
Data is collected from patient survey responses, medical records, and charts. Surveys are administered via email at specific time points. A deferred consent process is used, and participants are informed about their rights and the ability to withdraw. Data is deidentified for privacy.
Duration of Study:
The study is expected to take 14 months, with a 3-month recruitment phase, a 6-month follow-up period, and 5 months for data analysis and write-up. The estimated participation time for each participant is 13 minutes, and no reminders are sent.
Risks and Benefits:
There are no known risks to participants, and no direct benefits are provided. Personal data is protected, and participation is voluntary.
This study aims to contribute valuable insights into the quality of life of hernia surgery patients, particularly those who have undergone open tissue hernia repair at Shouldice Hospital.
Study Overview
Detailed Description
The proposed project is a pilot study designed in a prospective cohort manner, on primary unilateral inguinal hernia patients who had a Shouldice repair at the Shouldice Hospital. It includes prospective chart review (medical histories and operative notes) and a qualitative component (surveys). Patients will be emailed 5-7 days before surgery, with information inviting them to participate or read more about this research project, and a link to a full consent form. If patients consent they will be taken directly to the first (preoperative) survey and the same methodology will be used again at 1 week, 1 month, and 6 months after surgery. Contact is made by email using the hospital's current survey site: Simple Survey.
The survey is made up of the EQ5D3L, which is a standardized measurement of QOL (health related). The EQ5D3L contains two parts, one that measures health status through rating 5 questions in terms of having no, some or extreme problems with mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
The second part contains a visual analogue scale called EQVAS where participants rate their overall health from 0- worst imaginable to 100- best imaginable. The choice to use the EQ5D3L was made because it is a commonly used tool, has shown comparable results to other validated surveys like the CCS [6], and the EQ5D3L is a single short way to measure QOL. Although many studies use multiple surveys to assess QOL, for simplicity sake, and to reduce time burden on patients as well as prevent any reduced response rate just the EQ5D3L will be used.
The study population will focus on male and female patients aged 16-90 years of age, standard age of patients accepted for surgery at Shouldice Hospital, who had a Shouldice repair of a primary unilateral inguinal hernia at Shouldice Hospital, all nationalities and races, capable of speaking and reading English, in good general health, and there is no geographic location constraint. As there are no translators nor non-English survey options provided, participants who cannot complete the survey in English are excluded. Patients will be excluded if they underwent a mesh repair, a hernia that was not an inguinal type, a concurrent hernia, bilateral hernia repair, and surgery was deemed an emergency.
We aim to contact 1000 2400 patients to analyze a total of 400 participants. This is based off information gathered by the researchers from the first six weeks of recruitment for this project. this institution from previously done prospective projects. When consent forms were emailed, there was a response rate of 4530%, with a retention of patients meeting the criteria and being sent the follow up surveys at 18%. No dropout rate has been measured/considered as we will gather data for this pilot project to go on with a sample size calculation in the future. The 400 patients were concluded based off a multicenter study that used the EQ5D3L and had similar objectives as this present study. The 2018 study looked at survey responses after Lichtenstein repair with two difference meshes and had sample sizes of 411 and 397. Thus, analyzing 400 patients would allow for a meaningful comparison to open inguinal hernia repair.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Christoph Paasch, MD
- Phone Number: 435 9058891125
- Email: cpaasch@shouldice.com
Study Contact Backup
- Name: Marguerite Mainprize
- Phone Number: 297 9058891125
- Email: mmainprize@shouldice.com
Study Locations
-
-
Ontario
-
Thornhill, Ontario, Canada, L3T 4A3
- Recruiting
- Christoph Paasch
-
Contact:
- Christoph Paasch
- Phone Number: 435 9058891125
- Email: cpaasch@shouldice.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
The study population will focus on male and female patients aged 16-90 years of age, standard age of patients accepted for surgery at Shouldice Hospital, who had a Shouldice repair of a primary unilateral inguinal hernia at Shouldice Hospital, all nationalities and races, capable of speaking and reading English, in good general health, and there is no geographic location constraint. As there are no translators nor non-English survey options provided, participants who cannot complete the survey in English are excluded.
Exclusion Criteria:
Patients will be excluded if they underwent a mesh repair, a hernia that was not an inguinal type, a concurrent hernia, bilateral hernia repair, and surgery was deemed an emergency.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
EQ5D3L one week after surgery
Time Frame: one week after surgery
|
one week after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
EQ5D3L one month after surgery
Time Frame: one month after surgery
|
one month after surgery
|
|
EQ5D3L six months after surgery
Time Frame: ix months after surgery
|
ix months after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QoL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia, Inguinal
-
Children's Mercy Hospital Kansas CityCompletedInguinal Hernia | Inguinal Hernia, Indirect | Inguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalEnrolling by invitationInguinal Hernia | Strangulated Inguinal Hernia | Incarcerated Inguinal HerniaTurkey
-
Hospital General Universitario ElcheCompletedInguinal Hernia | Inguinal Hernia Repair | Open Inguinal Hernia
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Assiut UniversityRecruitingInguinal Hernia | Inguinal Hernia RepairEgypt
-
Damanhour Teaching HospitalCompletedInguinal Hernia UnilateralEgypt
-
Institute of Child HealthCompletedUnilateral Inguinal HerniaUnited Kingdom
-
University Medical Center GroningenSt Jansdal HospitalCompletedStrangulated Inguinal HerniaNetherlands
-
Insightra Medical, Inc.Terminated
-
Sohag UniversityRecruiting
Clinical Trials on no intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown